论文部分内容阅读
尽管多数非霍奇金淋巴瘤(NHL)初治患者, 通过经典的方案配合或不配合利妥昔单抗化疗能够得到缓解．但许多患者会复发。这些复发的患者和初次化疗无效的NHL患者是目前 NHL治疗的难点。
Although most non-Hodgkin’s lymphoma (NHL) naïve patients receive chemotherapy with classical regimens with or without rituximab, they can be alleviated. But many patients will relapse. These recurrences and patients with initial NHL ineffective NHL treatment is the current NHL treatment difficulties.